These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1490 related articles for article (PubMed ID: 27184250)

  • 61. Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.
    Maruyama M; Matsui T; Tanji H; Nemoto M; Tomita N; Ootsuki M; Arai H; Sasaki H
    Arch Neurol; 2004 May; 61(5):716-20. PubMed ID: 15148149
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional imaging in mild cognitive impairment and early Alzheimer's disease: is it pertinent?
    Ibáñez V; Deiber MP
    Front Neurol Neurosci; 2009; 24():30-38. PubMed ID: 19182460
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes.
    Mak E; Gabel S; Mirette H; Su L; Williams GB; Waldman A; Wells K; Ritchie K; Ritchie C; O'Brien J
    Ageing Res Rev; 2017 May; 35():250-264. PubMed ID: 27777039
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
    Li Q; Wu X; Xu L; Chen K; Yao L; Li R
    Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impaired glycemia increases disease progression in mild cognitive impairment.
    Morris JK; Vidoni ED; Honea RA; Burns JM;
    Neurobiol Aging; 2014 Mar; 35(3):585-9. PubMed ID: 24411018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.
    Assunção SS; Sperling RA; Ritchie C; Kerwin DR; Aisen PS; Lansdall C; Atri A; Cummings J
    Alzheimers Res Ther; 2022 Apr; 14(1):54. PubMed ID: 35440022
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis.
    Ding X; Yin L; Zhang L; Zhang Y; Zha T; Zhang W; Gui B;
    Alzheimers Dement; 2024 Jul; 20(7):4583-4593. PubMed ID: 38865281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.
    Gill S; Mouches P; Hu S; Rajashekar D; MacMaster FP; Smith EE; Forkert ND; Ismail Z;
    J Alzheimers Dis; 2020; 75(1):277-288. PubMed ID: 32250302
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.
    Koychev I; Lawson J; Chessell T; Mackay C; Gunn R; Sahakian B; Rowe JB; Thomas AJ; Rochester L; Chan D; Tom B; Malhotra P; Ballard C; Chessell I; Ritchie CW; Raymont V; Leroi I; Lengyel I; Murray M; Thomas DL; Gallacher J; Lovestone S
    BMJ Open; 2019 Mar; 9(3):e024498. PubMed ID: 30904851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
    Celsis P
    Ann Med; 2000 Feb; 32(1):6-14. PubMed ID: 10711572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.
    Li H; Habes M; Wolk DA; Fan Y;
    Alzheimers Dement; 2019 Aug; 15(8):1059-1070. PubMed ID: 31201098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
    Weiner MW; Veitch DP
    Alzheimers Dement; 2015 Jul; 11(7):730-3. PubMed ID: 26194308
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician.
    Budson AE; Solomon PR
    Neurologist; 2012 Nov; 18(6):356-63. PubMed ID: 23114667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pre-symptomatic detection of Alzheimer's disease and mild cognitive impairment].
    Arai H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):838-40. PubMed ID: 20030225
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment.
    Ma L; Chen J; Wang R; Han Y; Zhang J; Dong W; Zhang X; Wu Y; Zhao Z
    J Clin Neurosci; 2015 Apr; 22(4):649-52. PubMed ID: 25564275
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain structure and allelic associations in Alzheimer's disease.
    Moon SW; Zhao L; Matloff W; Hobel S; Berger R; Kwon D; Kim J; Toga AW; Dinov ID;
    CNS Neurosci Ther; 2023 Apr; 29(4):1034-1048. PubMed ID: 36575854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.